MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
MRTX
Delisted
MRTX was delisted on the 22nd of January, 2024.
177 hedge funds and large institutions have $3.36B invested in Mirati Therapeutics, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 68 increasing their positions, 57 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
177
Holders Change
+5
Holders Change %
+2.91%
% of All Funds
3.89%
Holding in Top 10
6
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-53.85%
% of All Funds
0.13%
New
29
Increased
68
Reduced
57
Closed
24
Calls
$221M
Puts
$159M
Net Calls
+$61.5M
Net Calls Change
-$44.3M
Top Buyers
1 |
O
OrbiMed
New York
|
+$41.7M |
2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$39M |
3 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$33.6M |
4 |
PA
Perceptive Advisors
New York
|
+$32.3M |
5 |
RI
RTW Investments
New York
|
+$26.3M |